Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Berris

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Digestive Diseases and Sciences|October 1, 1992
Effects of interferon-alpha therapy on serum and liver HBV DNA in patients with chronic hepatitis BS V Feinman, B Berris, R Sooknanan, et al.
Annals of Internal Medicine|November 1, 1973
Hepatitis B antigen in families of blood donorsB Berris, D M Wrobel, J C Sinclair, et al.
JAMA|March 8, 1976
Hepatitis B surface antigen and antibody in asymptomatic blood donorsJ C Sinclair, S V Feinman, D M Wrobel, et al.
Canadian Medical Association Journal|November 20, 1976
Practical guidelines for assessing patients positive for hepatitis B surface antigenS V Feinman, B Berris, J C Sinclair, et al.
American Journal of Ophthalmology|April 1, 1981
Removal of hepatitis B surface antigen from a contaminated applanation tonometerE Moniz, F Feldman, M Newkirk, et al.
Digestive Diseases and Sciences|April 1, 1981
Inability to detect hepatitis B surface antigen (HBsAg) in the duodenum of HBsAg-positive personsS V Feinman, B Berris, J C Sinclair, et al.
Canadian Medical Association Journal|May 19, 1973
Frequency of hepatitis B antigenW D Leers, D M Wrobel, V Feinman, et al.
JAMA|July 14, 1978
Hepatitis in undertakersB Berris, S V Feinman, B Richardson, et al.
Gastroenterology|January 1, 1975
Clinical and epidemiological significance of the HBSAg (Australia antigen): carrier stateS V Feinman, N Cooter, J C Sinclair, et al.
Hepato-Gastroenterology|April 1, 1982
Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier stateS V Feinman, B Berris, N Cooter, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Digestive Diseases and Sciences|October 1, 1992
Effects of interferon-alpha therapy on serum and liver HBV DNA in patients with chronic hepatitis BS V Feinman, B Berris, R Sooknanan, et al.
Annals of Internal Medicine|November 1, 1973
Hepatitis B antigen in families of blood donorsB Berris, D M Wrobel, J C Sinclair, et al.
JAMA|March 8, 1976
Hepatitis B surface antigen and antibody in asymptomatic blood donorsJ C Sinclair, S V Feinman, D M Wrobel, et al.
Canadian Medical Association Journal|November 20, 1976
Practical guidelines for assessing patients positive for hepatitis B surface antigenS V Feinman, B Berris, J C Sinclair, et al.
American Journal of Ophthalmology|April 1, 1981
Removal of hepatitis B surface antigen from a contaminated applanation tonometerE Moniz, F Feldman, M Newkirk, et al.
Digestive Diseases and Sciences|April 1, 1981
Inability to detect hepatitis B surface antigen (HBsAg) in the duodenum of HBsAg-positive personsS V Feinman, B Berris, J C Sinclair, et al.
Canadian Medical Association Journal|May 19, 1973
Frequency of hepatitis B antigenW D Leers, D M Wrobel, V Feinman, et al.
JAMA|July 14, 1978
Hepatitis in undertakersB Berris, S V Feinman, B Richardson, et al.
Gastroenterology|January 1, 1975
Clinical and epidemiological significance of the HBSAg (Australia antigen): carrier stateS V Feinman, N Cooter, J C Sinclair, et al.
Hepato-Gastroenterology|April 1, 1982
Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier stateS V Feinman, B Berris, N Cooter, et al.
Pageof 5